FASEB SRC on Protein Kinases, Cellular Plasticity and Signal Rewiring

Matthew L Freedman

4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci

All cancers but non-melanoma skin cancer

Alain Charest

(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Network

All cancers but non-melanoma skin cancer

Pathology

James McMahon

Molecular Targets Laboratory

All cancers but non-melanoma skin cancer

Chantal Guillemette

Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)

All cancers but non-melanoma skin cancer

Tarun M. Kapoor

Studying chromosome function using chemical biology

All cancers but non-melanoma skin cancer

Patrick G Harran

Fully Synthetic Prodiginines as Probes of Protein-Protein Interactions Regulating

All cancers but non-melanoma skin cancer

Radiation Oncology

Peter S Brzovic

Unconventional Interactions of Human Ubiquitin Conjugating Enzymes

All cancers but non-melanoma skin cancer

Deborah Johnson

Maf1, a novel negative transcriptional regulator of the TATA binding protein

All cancers but non-melanoma skin cancer

Paula Louise Fischhaber

Recruitment of End-Processing Factors in DSB Repair

All cancers but non-melanoma skin cancer